Article: Geron Corporation Reports Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors.

M2 PRESSWIRE-17 January 2007-Afternoon Movers: Geron Corporation Reports Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors(C)1994-2007 M2 COMMUNICATIONS LTD

RDATE:17012007

Geron Corporation (NASDAQ:GERN) is developing first-in-class biopharmaceuticals for the treatment of cancer and degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. The company is advancing an anticancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials. Geron is also the world leader in the development of human embryonic stem cell-based therapeutics, with its spinal cord injury ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!